MannKind Corp（MNKD）價格預測MNKDMannKind Corp

Alphio's MNKD stock price prediction model matches the current MannKind Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.05 (+0.25%). The 1-week path is $3.01 (-0.87%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

MannKind Corp is not a strong buy at the moment due to its current price of $3.04, which is significantly below analyst targets. The stock has a low RSI of 30.74, indicating oversold conditions, but it also has a high forward P/E of 25.71, suggesting potential overvaluation. The recent FDA approval for Furoscix and a revenue increase of 43% year-over-year are positive signs, but the company reported a net loss of $19 million in Q2 2026, which raises concerns about profitability. The main risk is the 337.78% increase in hedge fund selling, indicating a lack of confidence among institutional investors.

MannKind Corp (MNKD) last closed at $3.04, losing -4.70%. These facts feed the 1-day and 1-week MNKD price prediction above.